Tradestie Institutional Equity Comparison Engine
INBX vs KYMR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KYMR Overall Edge
KYMR Captures Institutional Edge (3โ0 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Kymera Therapeutics, Inc. Common Stock (KYMR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, INBX trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus KYMR at N/M Forward P/E and -396.0% operating margin (+466.4% YoY). In options structure, INBX sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro) against KYMR sits in CONSOLIDATION (23rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
INBX N/M vs KYMR N/M Fwd P/E
Growth & Margin Winner
KYMR
Op Margin 0.0% vs -396.0% ยท YoY -100.0% vs +466.4%
Momentum & Technical Winner
KYMR
1Y +3.6% vs +96.1% ยท 52W Pos 20% vs 78%
Options & Structure Winner
KYMR
BREAKDOWN (8th %ile IV) vs CONSOLIDATION (23rd %ile IV)
INBX
NASDAQ
Inhibrx Biosciences, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$77.32
-7.18% 1D
Market Cap
$1.3B
1M Return
-13.93%
1Y Return
+3.61%
Forward P/E
N/M
Unified AI Score
51.4 / 100
HOLD
Tech 48.0
Fund 55.0
Flow 68.0
Mom 50.0
KYMR
NASDAQ
Kymera Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$124.79
-2.18% 1D
Market Cap
$10.9B
1M Return
+19.1%
1Y Return
+96.12%
Forward P/E
N/M
Unified AI Score
47.1 / 100
HOLD
Tech 36.0
Fund 50.0
Flow 67.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
INBX +3.61%
KYMR +96.12%
Spread: +92.51 pp (KYMR Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | INBX Revenue | KYMR Revenue | INBX Op. Margin | KYMR Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | N/A | $0M | N/A | -1438.5% | KYMR |
| FY2020 | N/A | $30M | N/A | -136.1% | KYMR |
| FY2021 | N/A | $70M | N/A | -138.0% | KYMR |
| FY2022 | N/A | $50M | N/A | -344.4% | KYMR |
| FY2023 | $0M | $80M | -12178.9% | -210.6% | KYMR |
| FY2024 | $0M | $50M | -165724.0% | -555.8% | KYMR |
| FY2025 | $0M | $40M | -10386.5% | -891.1% | KYMR |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | INBX | KYMR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.3B | $10.9B | Larger Scale | KYMR |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -100.0% | +466.4% | Higher Growth | KYMR |
| Operating Margin (TTM) Profitability | 0.0% | -396.0% | Higher Margin | INBX |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -1773.6% | -27.3% | Higher ROE | KYMR |
| 52-Week Range Position Momentum | 20% ($57โ$155) | 78% ($62โ$143) | Stronger Trend | KYMR |
| Beta / 30D Volatility Risk Regime | 2.53ฮฒ ยท 120% Vol | 1.04ฮฒ ยท 54% Vol | Lower Realized Risk | KYMR |
| Unified Institutional Score Composite Signal | 51.4 / 100 (HOLD) | 47.1 / 100 (HOLD) | Higher Composite | INBX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full INBX vs KYMR Buy Guide
INBX
BREAKDOWN
134d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
8th %ile
IV Regime
Compressed (<25th %ile)
KYMR
CONSOLIDATION
62d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
23rd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither INBX nor KYMR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.